SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Disco Pharmaceuticals Announces Collaboration With AbbVie on Bispecific Therapeutics

Disco Pharmaceuticals announced a collaboration with AbbVie to advance next-generation AND-gated bispecific therapeutics for solid tumors.

ABBV

Related stories